U
Urovant Sciences
0 followers
Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist
Org chart
James Robinson
President & CEO
Collapse
Betzy Estrada
EVP & Chief Human Resources Officer
Laura Genatossio
SVP & General Manager, Europe
Mark Niemaszek
SVP, Corporate Planning
Alana Darden Powell
VP, Marketing
Achsah Warren
Vice President Compliance
David Musselman
Vice President, Sales And Commercial Strategy
Tom Cunningham
Director Commercial Manufacturing
Marc Oseroff
Senior Territory Sales Manager
Jeremy Bolton
Senior Director, Global Supply Chain
C. Rick Jarecke
Executive Director, Medical Affairs, Urovant Sciences
John Patrick Rodriguez
Director, Accounting
Board & advisors
Myrtle Potter
Chairman
Keith Katkin
Advisor to the Board
James M. Hindman
Board Member
Pierre Legault
Board Member
Shigeyuki Nishinaka
Board Member